News & Views
Manufacturing Facility Granted ISO 9001:2015
Feb 23 2019
A leading provider of recombinant antibodies has received ISO 9001:2015 for its Redcar-based manufacturing facility as of December 17, 2018. The certification strengthens Absolute Antibody’s diagnostic offerings, which enable customers worldwide to use antibody sequencing, engineering and expression services to develop diagnostic assays. The antibodies, said to be delivered in any format, offer potential for use by diagnostic developers as well as researchers working in pharmaceuticals, biotechnology and academia.
“Receipt of our ISO 9001:2015 certification demonstrates our company’s commitment to our customer base,” said Dr. Nicholas Hutchings, founder and CEO of Absolute Antibody. “Our goal has always been to deliver the highest level of quality and customer satisfaction. We are proud to have an excellent quality management system (QMS) in place to measure and monitor for consistent outcomes, which will increase our efficiency and productivity, furthering our capabilities to offer antibodies for the diagnostics market.”
During the past year, Absolute Antibody merged with Boston-based Kerafast, Inc. to expand their product and service portfolio and to provide more efficient delivery to its large North American customer base. Fueled by the recent increase in adoption of recombinant antibody technology, the company has grown significantly, and adherence to ISO 9001:2015 guidelines will enable Absolute Antibody to continue to expand its catalogue and custom service offerings.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan